Basic Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Aug 27, 2023; 15(8): 1600-1614
Published online Aug 27, 2023. doi: 10.4240/wjgs.v15.i8.1600
Table 1 Clinical characteristics of hepatocellular carcinoma patients in The Cancer Genome Atlas database, n (%)
CharacteristicLow expression of SKA3
High expression of SKA3
P value
n = 187
n = 187
Age0.034
    ≤ 6078 (44.1)99 (55.9)
    > 60109 (55.6)87 (44.4)
Sex0.269
    Female55 (45.5)66 (54.5)
    Male132 (52.2)121 (47.8)
Race0.008
    Asian65 (40.6)95 (59.4)
    Black or African American9 (52.9)8 (47.1)
    White106 (57.3)79 (42.7)
T stage0.031
    T1105 (57.4)78 (42.6)
    T241 (43.2)54 (56.8)
    T333 (41.2)47 (58.8)
    T45 (38.5)8 (61.5)
N stage1.000
    N0119 (46.9)135 (53.1)
    N12 (50)2 (50)
M stage0.355
    M0128 (47.8)140 (52.2)
    M13 (75)1 (25)
AFP (ng/mL)< 0.001
    ≤ 400124 (57.7)91 (42.3)
    > 40017 (26.2)48 (73.8)
Child-Pugh grade0.813
    A 118 (53.9)101 (46.1)
    B10 (47.6)11 (52.4)
    C1 (100)0 (0)
Pathologic stage0.024
    Stage I98 (56.6)75 (43.4)
    Stage II39 (44.8)48 (55.2)
    Stage III34 (40)51 (60)
    Stage IV4 (80)1 (20)
Vascular invasion0.121
    No115 (55.3)93 (44.7)
    Yes50 (45.5)60 (54.5)